CD4 and hepatocellular carcinoma: Consistent with these results, ex vivo experiments performed by Hoechst and colleagues demonstrated that blood derived CD14+HLA-DR−−/ myeloid cells isolated from hepatocellular carcinoma (HCC) patients induce CD4+CD25+Foxp3+ Treg when co-cultured with autologous T cells (44).